T-DM1 is an antibody-drug conjugate combining trastuzumab (Herceptin) with mertansine, used to treat recurrent metastatic breast cancer previously treated with a different trastuzumab drug conjugate.
T-DM1 is een antilichaam-geneesmiddel conjugaat dat trastuzumab (Herceptin) combineert met mertansine. Het wordt gebruikt voor de behandeling van terugkerende gemetastaseerde borstkanker die eerder behandeld is met een ander trastuzumab-geneesmiddel conjugaat.
| Front | An antibody-drug conjugate combining trastuzumab Herceptin with mertansine used to treat recurrent metastatic breast cancer previously treated with a different trastuzumab drug conjugate |
|---|---|
| Back | T-DM1 |
Learn with these flashcards. Click next, previous, or up to navigate to more flashcards for this subject.
Next card: Humanized anti-il-6 receptor antibody treating rheumatoid arthritis tocilizumab
Previous card: Drug inhibitors hmg-coa reductase lower cholesterol statins
Up to card list: Janeway's Immunobiology 9th Edition Concept Flash Card